Phase 3 Chickenpox Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years
Varicella (Chickenpox)Chickenpox Vaccine
GC Biopharma Corp474 enrolled1 locationNCT07054099
Recruiting
Phase 3
Second Dose of Varicella Vaccine in Healthy Children
Varicella (Chickenpox)Varicella Immunisation
Sinovac (Dalian) Vaccine Technology Co., Ltd.300 enrolled5 locationsNCT07475000
Recruiting
Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline900 enrolled12 locationsNCT06855160
Recruiting
Phase 3
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline600 enrolled3 locationsNCT06806137
Recruiting
Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline1,840 enrolled5 locationsNCT06740630
Recruiting
Phase 3
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline750 enrolled1 locationNCT06693895